420 with CNW – Why Columbia Could Reshape the Canadian Cannabis Landscape

The big pot stocks in Canada, such as Tilray Inc., Canopy Growth Corp. and Aurora Cannabis may soon have to contend with an emerging threat as marijuana growers in North America start moving their farms across the border to Columbia.

This migration is eerily similar to what happened to the growers of rose flowers who all moved south to low-cost Columbia.

Paul Henderson, the owner of Grupo Flor (a cannabis cultivation company based in Monterey) is the trailblazer of this migration. He predicts that North American marijuana growers in Canada will suffer the same fate that rose growers experienced. Practically no rose grower was left in Monerey once cultivation starting moving south.

Henderson adds that within the next decade, the cannabis industry will transition into a phase of commoditization. As that happens, it will become increasingly untenable to keep growing marijuana in Canada when Columbia is just a short distance away.

Henderson’s company is currently getting a 1,000,000 square-foot cultivation facility ready on the outskirts of Cali, a city found close to the Equator in Columbia. He boasts that when the facility starts operations, his company would be able to cut the price of its produce by 90 percent and still make a profit, something that growers who are still based in Canada cannot do and stay afloat.

Columbia enjoys several advantages which are only a dream to Canadian cannabis growers. First, the climate in Columbia is so good that the cultivation facilities there don’t require elaborate climate-control systems. Secondly, the labor in Columbia is highly skilled yet more affordable than what is available in Canada.

These reduced production costs put Columbia firmly on course to attain the target of producing a gram of cannabis at just 50 Canadian cents ($0.38) and yet the long-term goal of cannabis production in Canada is to bring the cost of a gram down to CAD $2 ($1.51) . That is a whole world of difference in production costs!

Columbia legalized medical cannabis for domestic use as well as export. This policy shift is responsible for the interest of Canadian cannabis growers in shifting their operations to Columbia.

The emergence of Columbia as a destination for Canadian cannabis cultivators has come at a time when the cannabis industry in Canada has just been dealt a blow by the U.S. FDA. The regulators are reluctant to legalize CBD and it appears to be headed for regulatory oversight by the FDA. This has dampened the hopes of Canadian firms that were gearing up to enter the U.S. CBD market.

Cannabis industry watchers are wondering what major players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International Inc. (NASDAQ: YGYI) can do to respond to developments like transferring marijuana cultivation facilities to another country different from the country where the company has its major operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Arizona Medical Cannabis Dispensaries Celebrate Supreme Court Decision on Concentrates as Sales Soar

In a 7-0 emphatic decision, the Supreme Court of Arizona has quashed a ruling by the Court of Appeal to the effect that marijuana concentrates, such as hashish, were not included in the law which legalized medical marijuana in the state.

This case arose after Yavapai County convicted a patient with a valid medical marijuana card issued by the state for possessing hashish. In their ruling delivered on Tuesday (May 28), the justices affirmed that the law legalized all forms of the cannabis plant, including the concentrates made from any segments of the plant that manufacturers deemed fit for processing.

For over a year, the decision of the Court of Appeal had stood and restricted the potentially explosive growth of the cannabis concentrates industry since the court ruling had excluded concentrates from the products envisaged by the 2010 law.

The cannabis extracts sold in medical marijuana dispensaries across the state include soda, candy, vape pens, food and many other products. Records show that the sale of cannabis concentrates is growing at a faster pace when compared to marijuana flower. For example, in the year ending April 2019, sales of cannabis flower grew by 33 percent while sales of concentrates surged by 71 percent in the same period. The 71 percent growth doesn’t include cannabis edibles.

It would therefore have been damaging (and strange) if the highest court has upheld the decision of the lower court. Many jurisdictions where medical marijuana is legal only allow extracts, such as cannabis oil, tinctures, creams, gels and ointments. These include Pennsylvania which only accepted smokable cannabis recently.

It is noteworthy that the dispensaries and manufacturers, such as Item 9 Labs, only paused cannabis concentrate sales briefly after the Court of Appeal ruling and then continued business as usual after their legal teams advised them that there was no legal basis for banning the concentrates.

The legal counsel of those companies has now been vindicated after the Supreme Court pronounced itself on the matter.

Patients have welcomed the latest ruling since the decision ensures that they will continue accessing marijuana concentrates. Many of the patients on the medical marijuana program are either unable or unwilling to smoke medical marijuana. Concentrates also provide a precise way to determine the dosage consumed, an attribute which is vital if the desired therapeutic effects are to be attained.

Lindsey Bartels, a patient who lives in Tempe and has battled chronic pain for years, admitted as much when she said cannabis oil allows her to live a normal life. Youngevity International Inc. (NASDAQ: YGYI), Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and the entire cannabis industry welcomes the court decision in Arizona which has given patients like Lindsey Bartels hope that they will continue having access to cannabis concentrates which have proved immensely helpful in improving the quality of their lives.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – University of Washington to Study Effects of Cannabis Use During Pregnancy

There’s minimal scientific information about the potential effects of the different drugs which pregnant mothers are discouraged from taking, but cannabis is singled out and given a very negative connotation even if there’s no proof to show whether it is as dangerous, or more dangerous, than pharmaceutical drugs. To set the record straight, researchers from the University of Washington are now recruiting study subjects to research how cannabis use during pregnancy affects babies after they are born.

The “Moms + Marijuana” study will document pregnant mothers’ use of marijuana from the first trimester of pregnancy until birth. The babies born will then have their brains scanned at six months of age to determine how prenatal marijuana use affects the cognitive, psychomotor and behavioral development of infants.

The study is focusing on pregnant women who are already using cannabis to manage the conditions, such as nausea, which they are suffering from during pregnancy. The objective is to find scientific proof either in support of, or contradicting the advice given to pregnant women to abstain from using marijuana.

To this end, the researchers are on a drive to recruit 70 pregnant women who are still in the first trimester of pregnancy. Half of these women will be in the test group while the other half will be in the control group.

Those in the control group will not be allowed to take any cannabis, tobacco or alcohol while those in the test group will be allowed to consume marijuana at least two times each week. The marijuana will be used to control morning sickness.

The researchers intend to conduct random drugs tests throughout the study in order to confirm that the pregnant women aren’t using any other drugs apart from what they are self-reporting to the researchers.

The test group of pregnant women are required to report their weekly marijuana use, and that marijuana can only be bought from licensed sources. The women will also send photos of the cannabis package so that the THC and CBD concentration in that marijuana will be recorded.

When the babies of the research subjects reach six months of age, they will be tested to establish their social and cognitive development, their motor and communication skills, their temperament and other behavioral markers.

Magnetic Resonance Imaging (MRI) scans will also be done while the babies are asleep. During those scans, the babies will be exposed to an odor of phenyl-ethanol. This substance is known to activate the sections of the brain which are associated with addiction and reward. The researchers want to use these scans to assess how prenatal marijuana use affects this part of the brain.

Once all this data has been collected, the researchers will compare the findings from the two groups and determine what role marijuana has had on the development of the babies. Youngevity International Inc. (NASDAQ: YGYI) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that this research will provide conclusive proof of whether prenatal cannabis use should or shouldn’t be recommended.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Oregon Legislators Discuss Exporting Marijuana Surplus

The production of marijuana in Oregon is so high that the Oregon Liquor Commission estimates that the available inventory can address the supply needs of the state for nearly 7 years if demand remains at the current level. This overproduction has prompted lawmakers to consider exporting the excess cannabis to other jurisdictions where recreational marijuana is legal.

Senate Bill 582 is a preemptive step aimed at getting Oregon ready to move fast once the federal government relaxes its marijuana laws. Currently, marijuana is a schedule 1 controlled substance which cannot cross state lines.

Cannabis law reform at the federal level is expected to take one of two forms in the foreseeable future. First, the States Act which is before Congress seeks to get federal recognition that states have a right to make and implement their own marijuana laws without interference from the feds.

Alternatively, a statement by the Justice Department to the effect that the transfer of marijuana between states wouldn’t be a “priority for law enforcement” at the federal level can be interpreted to mean that states which have legalized marijuana can trade the substance between themselves.

Mike Getlin, a cannabis law reform advocate, says that should marijuana trade between states become a reality and Oregon isn’t poised to jump right in from the very onset, then a delay of even six months would be sufficient to knock the state out of contention as a major player in the interstate cannabis trade. Such an eventuality would flip the oversupply in Oregon from an asset to a major problem which can cripple the state’s cannabis industry.

SB 582 has provisions which would allow the Governor of Oregon to negotiate arrangements through which Oregon’s surplus marijuana can be sold to states where more supply is needed. The bill stipulates that only states where recreational marijuana is legal are eligible for an export and sale arrangement with Oregon.

Casey Houlihan, the head of the Oregon Cannabis Retailers Association, testified before the senate committee and revealed that the excess cannabis in Oregon will find its way to other states one way or the other, so it is better for mechanisms to be put in place so that the export can be done in a regulated way that brings revenue to state coffers.

Some of the cannabis companies that testified before the senate committee revealed that they had reduced their workforce by up to 80 percent because of the drop in marijuana prices due to oversupply within Oregon.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International, Inc. (NASDAQ: YGYI) look forward to a viable solution that can save the cannabis industry in Oregon from collapsing due to excess production.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Texas Lawmakers to Vote on Cannabis Decriminalization This Week

About a month ago, the Texas House Jurisprudence Committee passed a bill that would make low-level cannabis possession a crime punishable by a fine rather than jail time. That bill is now before the House and it will be voted on this week (Thursday).

If the bill becomes law, anyone found in possession of an ounce or less of marijuana would pay a fine of $250. Such a crime would then become a Class C misdemeanor if one is caught more than twice.

Under the current law, anyone who is found with two ounces or less of marijuana can be fined a maximum of $2,000 as well as serve 180 days in jail. Whether one pays the fine or goes to jail, they remain with a permanent criminal record that can affect them for life.

While Texas is known for being conservative, there is growing consensus that cannabis laws need to be reformed, and that is why the decriminalization bill has bipartisan support. People want to see the meager public resources devoted to more serious crimes instead of using those resources to prosecute people for minor cannabis possession infractions.

This change of heart among conservative Texans has seen various bills get House Committee approval. The decriminalization bill is one of the three most notable cannabis reform bills.

The second bill that passed at committee level is a bill to legalize industrial hemp and its derivatives. This bill was passed on Tuesday this week. If it becomes law, hemp would no longer be a controlled substance in the state.

A third bill seeks to expand the medical marijuana program in the state. This bill got unanimous support when a vote was called last week. One of the changes introduced by this bill included adding more than a dozen health conditions to the list of medical marijuana qualifying conditions.

All these three bills were supported by the Republicans in those different committees. Gov. Greg Abbott, a Republican, has also promised to sign the bills once they reach his desk after getting legislative approval.

This piecemeal way of easing marijuana laws may eventually culminate in the legalization of recreational marijuana in Texas, although the Republican Party hasn’t explicitly stated that it supports legalization in the state.

Cannabis Strategic Ventures Inc. (OTC: NUGS), Youngevity International Inc. (NASDAQ: YGYI) and the entire cannabis industry welcome the incremental cannabis policy reforms being instituted in Texas. Such an approach ensures that there will be minimal friction in implementing the changes needed for Texans to benefit fully from the cannabis industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Inhalers Could Be the Next Asthma and Cancer Pain Medication

Whole smoking is the most common administration method for medical cannabis, not all patients are willing or able to use this method. For example, those who have respiratory challenges like asthma are unable to smoke cannabis because it may aggravate their condition. Terminally ill patients may also find it hard to smoke marijuana as part of their treatment. For such patients, two Israeli companies have teamed up to develop cannabis inhalers through which they can take their medication.

The two firms are Panaxia Pharmaceuticals and Rafa Pharmaceuticals. The two companies are working together to bring marijuana inhalers to the market so that patients have one more way to get their medication.

For now, the companies are targeting asthma and the pain suffered by cancer patients. The companies hope to avail an administration mode that will bring quick relief to cancer pain or respiratory distress resulting from asthma symptoms.

This administration mode may easily gain acceptance in the market for several reasons.

First, inhalers aren’t a new mode of administering medication to patients. Asthma sufferers carry them around, so it would not be hard for them to switch to the cannabis version.

Secondly, it is possible to determine what precise dose of cannabis a patient should receive when using inhalers since the patient can be told to inhale a given number of times at stipulated intervals in order to get the right dose of cannabis into the body. Medical practitioners can therefore easily see cannabis as medicine if its dosage can be controlled.

Additionally, inhalation can provide faster therapeutic outcomes when compared to other modes, such as consuming cannabis edibles. This is precisely why asthma sufferers often carry an inhaler so that they can use it and see results faster when an asthma attack occurs.

At the moment, the innovators are conducting clinical trials together with the Israeli Ministry of Health in order to ascertain whether the product is ready to hit the market, or some kinks remain which need to be resolved.

Meanwhile, the companies have decided to start a marketing drive for the inhalers while the clinical trial is ongoing.

The plan is to avail the inhalers on the Israel market later this year. Only patients with a doctor’s prescription will be able to access the product. It is not yet clear when the two companies will start exporting their invention to the rest of the world. Remember, the Israeli parliament passed a law towards the end of last year allowing companies that have been licensed by the state to export medical marijuana.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulate the two Israeli companies for finding a solution to administering medical cannabis to patients who are unable to use the modes that are currently available on the market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBD Industry Set to Explode as New Products, Consumers Enter Market

CannabisNewsWire Editorial Coverage: The U.S. Farm Bill that recently passed into law is a game-changer for the CBD space. While it is unknown when nationwide cannabis legalization may occur, incredible opportunities exist right now for CBD-focused companies that can deliver products to the marketplace.

  • Demand is growing for organic CBD products in markets where such products are legal.
  • Youngevity has made a series of strategic acquisitions to help establish the company’s position
  • Companies ready to deliver CBD products to market at scale are in ideal position to capitalize on growing demand.

Passage of the latest U.S. Farm Bill marked a watershed moment for CBD producers in the United States. Not only does the new body of law allow these producers to commercialize existing CBD products, the door is now open for a new generation of research into what CBD can do for consumers. Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is a leading producer of consumer-focused CBD products that is expanding its reach into other areas of the CBD supply chain. It joins companies such as CV Sciences Inc. (OTCQB: CVSI), Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF), GW Pharmaceuticals plc (NASDAQ: GWPH) (OTC: GWPRF), and Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA), which are all working to commercialize CBD products in both…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – 50 Marijuana Dispensaries in Michigan Get Temporary Reprieve in Court

On Thursday last week (March 28), Judge Stephen Borrello of the Michigan Court of Claims issued a temporary order stopping the state from implementing its decision to close down any medical marijuana dispensary that hadn’t received its license by March 31.

The restraining order gives the businesses in question another 14 days within which to get their operations legalized in accordance with the licensing requirements of the state.

For long, players in the Michigan medical marijuana industry have been complaining that the state takes an inexplicably long time to process and issue a license to an applicant. This slow bureaucratic pace has affected growers, manufacturers and dispensing outlets.

For example, in early February alone, about 150 dispensaries were still awaiting the outcome of their applications for licenses. Similarly, 130 prospective medical cannabis cultivators were also awaiting the fate of their applications for grow licenses.

Because of those complaints, the state decided to allow medical cannabis businesses to open while their applications were still being processed.

However, the state eventually set deadlines for all unlicensed dispensaries to close, but these deadlines have either been unilaterally postponed by the regulators or courts have intervened and forced the state’s hand.

This recent extension is an example of the judiciary stepping in and compelling the state to refrain from implementing its decision to close medical marijuana businesses without licenses.

In response to the restraining order issued by the Court of Claims, the state published a statement in which it revealed that it will hit the brakes on its decision to close unlicensed medical cannabis businesses until court issues further orders or the pending litigation is disposed of by the courts of law.

In a bid to put an end to the endless delays in the licensing process, the Governor of Michigan, Gretchen Whitmer, has established a new agency to superintend over the marijuana industry.

The persistent problems over licensing issues have also come to a head as the state is working to start recreational cannabis sales after voters approved adult-use marijuana during the midterm elections towards the end of last year.

Cannabis advocates worry that if the problems in the medical cannabis sector aren’t fixed in time, then those problems will get worse once recreational cannabis is added to the menu. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International, Inc. (NASDAQ: YGYI) call on the regulators to study what other states have done to streamline the licensing process. Creating new agencies to oversee the industry may not fix the problem if a proper diagnosis of the issues isn’t done.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Research Suggests You Could Be Storing Cannabis Improperly

Ask anyone how they store their cannabis and you are likely to hear that they place it in an airtight plastic container stored away from direct sunlight. While this has been the norm for cannabis storage, new research suggests that such a method may not preserve the ingredients of your valuable stash for long.

The Italian study compared how THC content was preserved if cannabis was stored in four different ways for 100 days.

First, the researchers looked at what would happen to cannabis if it were stored for 100 days in a bright room at room temperature. This method of storage resulted in a 13 percent drop in the THC content of the cannabis.

The researchers also looked into what would happen to the THC content of cannabis that has been stored in a dark room at room temperature. The cannabis lost 11 percent of its THC content.

How do most processors store their cannabis? You guessed right, in a dark room at room temperature. These manufacturers may be slapping themselves in the face as they read this!

Next, the researchers looked at what would happen if a batch of cannabis was stored inside a refrigerator whose temperature was maintained at 4°C. There was a substantial reduction in the drop of THC using this method of storage.

The researchers then upped the ante and kept some marijuana in a freezer for 100 days. The temperature inside the freezer was maintained at -20°C. Tests revealed that there was no noticeable change in the THC content if the cannabis was stored in the freezer.

The researchers concluded that the best way to store cannabis in order to preserve its constituents was by freezing it. Storage in an airtight container in a dark room only works for short-term storage, they added.

The researchers also revealed that the CBD content of cannabis barely changes over time regardless of how you choose to store the marijuana. People who have no interest in THC shouldn’t therefore fret about how they keep their cannabis products.

However, the findings of this study should not be generalized as applicable to all the attributes or components of cannabis. For example, the study didn’t look into how the flavor or scent of cannabis was affected by the four storage methods investigated.

As you wait for research to be done on that, you can conduct your own little experiments to see how your perception of those attributes is affected when you store marijuana in different ways.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome the insights that the study has shed on the different storage options for cannabis products.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Drink Companies Prepare for the Coming of CBD Beverages

CannabisNewsWire Editorial Coverage: CBD-infused beverages look set to hit the market in a big way in 2019.

  • Cannabidiol (CBD) is widely used in health and wellness products after spectacular growth in recent years.
  • Several companies are lining up to launch CBD drinks following legal changes in the United States and Canada.
  • Integrating these new offerings into wider product lines is accelerating CBD’s race for mainstream attention.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is one of the first to launch, with a CBD coffee coming in May and a CBD water in the works. The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), which is constantly growing its U.S. distribution network, plans to add a CBD bottled water to its range. The New Age Beverages Corporation (NASDAQ: NBEV) is adding CBD to its line of organic cold coffees and teas. Heineken (OTCQX: HEINY) has also entered the market by developing a cannabis-infused sparkling water through Lagunitas, its U.S. craft brewer. And the biggest investment in the overall cannabis space has come from Constellation Brands Inc. (NYSE: STZ), which has invested…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.